Evidence map›Paper›PMID 41912533›Full record

ArticleNature communications2026

Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype.

Ilaria Parenti, Alina Hesters, Marta Gil-Salvador, Laura Duffy, Deniz Kanber, Jasmin Beygo, Jennifer Kerkhof, Laura Steenpaß, Elsa Leitão, Julia Woestefeld and 46 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

56 authors.

Ilaria ParentiInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. ilaria.parenti@uk-essen.de.ORCID 0000-0002-1825-6237
Alina HestersInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID 0009-0000-8039-3040
Marta Gil-SalvadorUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, Zaragoza, Spain.ORCID 0000-0001-6858-1575
Laura DuffyVerspeeten Clinical Genome Centre, London Health Science Centre, London, ON, Canada.ORCID 0009-0007-3297-7747
Deniz KanberInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Jasmin BeygoInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Jennifer KerkhofVerspeeten Clinical Genome Centre, London Health Science Centre, London, ON, Canada.ORCID 0000-0003-1245-6606
Laura SteenpaßHuman and Animal Cell Lines, Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, Germany.
Elsa LeitãoInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0001-5051-9714
Julia WoestefeldInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-9796-2323
Philip M BooneDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Emeline M KaoInstitutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA.
Lama AlabdiDepartment of Translational Genomics (Genomic Medicine Centre of Excellence (GMCoE)), King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Hesham M AldhalaanAutism Department King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Fowzan S AlkurayaDepartment of Translational Genomics (Genomic Medicine Centre of Excellence (GMCoE)), King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Muneera J AlshammariDepartment of Pediatrics, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Stylianos E AntonarakisMedigenome, Swiss Institute of Genomic Medicine, Geneva, Switzerland.ORCID 0000-0001-8907-5823
Donald BaselDivision of Genetics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Kevin CassinariDepartment of Genetics and Reference Center for Developmental Disorders, Univ Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, Rouen, France.
Laurana de Polli CellinGenetic Endocrinology Unit, Endocrinology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
Amanda R ClauseIllumina Laboratory Services, Illumina Inc., San Diego, CA, USA.ORCID 0000-0002-2078-7280
Alexander Augusto de Lima JorgeGenetic Endocrinology Unit, Endocrinology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-2567-7360
Andréa de Castro LealDepartment of Integrated Health, State University of Para, Santarem, Brazil.ORCID 0000-0003-1284-8618
Stephan C CollinsUniversité Bourgogne-Europe, Inserm U1231, Dijon, France.ORCID 0000-0002-1533-3380
Benjamin DurandService de Génétique Médicale, Institut de Génétique Médicale d'Alsace (IGMA), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0003-3434-1172
Juliane EckholdInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Mais O HashemDepartment of Translational Genomics (Genomic Medicine Centre of Excellence (GMCoE)), King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Parul JayakarDivision of Genetics & Metabolism, Nicklaus Children's Hospital, Miami, FL, USA.
Arif O KhanOphthalmology, Integrated Surgical Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
Kohji KatoSchool of Biochemistry, Faculty of Life Sciences, University of Bristol, Bristol, UK.
Regina KubicaInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Gholson J LyonDepartment of Human Genetics, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.ORCID 0000-0002-5869-0716
Elaine MarchiDepartment of Human Genetics, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.
Julie McCarrierDivision of Genetics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Lara K KimmigInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Seiji MizunoDepartment of Pediatrics, Aichi Developmental Disability Center, Kasugai, Japan.
Gael NicolasDepartment of Genetics and Reference Center for Developmental Disorders, Univ Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, Rouen, France.ORCID 0000-0001-9391-7800
Yosuke NishioDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0003-3543-7491
Tomoo OgiDepartment of Genetics, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.ORCID 0000-0002-5492-9072
Juan PiéUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, Zaragoza, Spain.
Jordyn PrellDivision of Genetics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Beatriz PuisacUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, Zaragoza, Spain.ORCID 0000-0003-0170-7326
Feliciano J RamosUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology and Physiology, School of Medicine, University of Zaragoza, CIBERER and IIS-Aragon, Zaragoza, Spain.ORCID 0000-0002-5732-2209
Emmanuelle RanzaMedigenome, Swiss Institute of Genomic Medicine, Geneva, Switzerland.
Claire RedinMedigenome, Swiss Institute of Genomic Medicine, Geneva, Switzerland.
Eric RushDivision of Clinical Genetics, Children's Mercy Kansas City, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA.
Shinji SaitohDepartment of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan.ORCID 0000-0001-6911-3351
Hanan E ShamseldinDepartment of Translational Genomics (Genomic Medicine Centre of Excellence (GMCoE)), King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Susan StarlingDivision of Clinical Genetics, Children's Mercy Kansas City, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA.
Esteban Astiazaran-SymondsDepartment of Medicine, College of Medicine-Tucson, University of Arizona, Tucson, AZ, USA.
Sara H EltahirDepartment of Pediatrics, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Alma KuechlerInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Bekim SadikovicVerspeeten Clinical Genome Centre, London Health Science Centre, London, ON, Canada.ORCID 0000-0001-6363-0016
Binnaz YalcinUniversité Bourgogne-Europe, Inserm U1231, Dijon, France.ORCID 0000-0002-1924-6807
Kerstin S WendtErasmus Medical Centre, Department of Developmental Biology, Rotterdam, The Netherlands.ORCID 0000-0003-0235-1237
Frank J KaiserInstitute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Funding

Defining the Disorders of Genome OrganizationK08NS117891 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BOONE, PHILIP MICHAEL · 2020 to 2024
$988k
NINDS NIH HHS K08 NS117891
6 · The paper itself

Abstract

The role of the cohesin complex depends on the cohesin loader proteins NIPBL and MAU2. While NIPBL variants are a major cause of Cornelia de Lange Syndrome (CdLS), the role of MAU2 in disease is unclear. We describe 18 individuals carrying 15 heterozygous MAU2 variants and demonstrate pathogenicity through functional analyses. In-frame MAU2 variants predominantly impair NIPBL-MAU2 interaction, whereas truncating variants cause MAU2 haploinsufficiency and lead to NIPBL reduction. Most individuals exhibit a DNA methylation profile compatible with the CdLS episignature. We also describe two MAU2-specific episignatures that reflect variant-dependent molecular consequences. Affected individuals display a wide range of phenotypes, from classic CdLS to milder presentations, with short stature and microcephaly as major features. A heterozygous Mau2 knockout mouse model recapitulates these traits, confirming the causal role of MAU2 disruption in vivo. Our study establishes MAU2 as a CdLS-associated gene and delineates a MAU2-related chromatinopathy with variable expressivity.

Indexed as

De Lange SyndromeProteinsAnimalsCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDNA MethylationFemaleHaploinsufficiencyHeterozygoteHumansMaleMiceMice, KnockoutMutationPedigreeCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsNIPBL protein, humanProteins

Identifiers

PMID41912533
PMCPMC13035837

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.